Allogene Therapeutics Inc... (ALLO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.86
-0.06 (-3.12%)
At close: Jan 15, 2025, 3:59 PM
1.87
0.27%
After-hours Jan 15, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 83.16M | 576.47M | 809.48M | 1.03B | 588.86M | 721.35M | n/a |
Short-Term Investments | 365.54M | 455.42M | 283.99M | 644.56M | 355.41M | 366.95M | n/a |
Long-Term Investments | 3.65M | 59.15M | 370.18M | 207.95M | 63.21M | 261.97M | n/a |
Other Long-Term Assets | 16.90M | 32.67M | -322.05M | 14.62M | 8.92M | 1.54M | n/a |
Receivables | n/a | n/a | n/a | n/a | 2.40M | 3.11M | n/a |
Inventory | n/a | -62.45M | -20.02M | -207.01M | -60.73M | -261.97M | n/a |
Other Current Assets | 10.42M | 11.50M | 8.02M | 10.62M | 11.64M | 5.49M | n/a |
Total Current Assets | 459.12M | 528.82M | 809.48M | 845.13M | 544.58M | 467.98M | n/a |
Property-Plant & Equipment | 163.18M | 196.43M | 181.02M | 160.13M | 100.94M | 41.61M | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | 151.00K | 754.00K | n/a |
Total Long-Term Assets | 183.72M | 288.25M | 229.15M | 382.70M | 173.23M | 305.87M | n/a |
Total Assets | 642.84M | 817.08M | 1.04B | 1.23B | 717.80M | 773.86M | n/a |
Account Payables | 5.90M | 13.89M | 10.26M | 10.39M | 9.25M | 12.34M | n/a |
Deferred Revenue | 86.00K | 885.00K | 423.00K | 38.99M | n/a | n/a | n/a |
Short-Term Debt | 6.78M | 6.00M | 3.20M | 2.97M | 1.68M | n/a | n/a |
Other Current Liabilities | 24.32M | 33.84M | 34.72M | 41.96M | 22.15M | 17.12M | 2.00K |
Total Current Liabilities | 37.08M | 54.52M | 48.17M | 94.32M | 33.08M | 29.46M | 2.00K |
Long-Term Debt | 88.35M | 95.12M | 69.93M | 50.81M | 51.35M | 34.46M | n/a |
Other Long-Term Liabilities | 5.18M | 5.85M | 4.13M | 3.08M | 4.35M | 6.78M | n/a |
Total Long-Term Liabilities | 93.53M | 96.69M | 74.05M | 53.89M | 55.70M | 41.23M | n/a |
Total Liabilities | 130.60M | 151.21M | 122.23M | 148.21M | 88.78M | 70.69M | 2.00K |
Total Debt | 95.12M | 95.12M | 69.93M | 53.78M | 51.35M | 34.46M | n/a |
Common Stock | 169.00K | 144.00K | 142.00K | 140.00K | 124.00K | 121.00K | 26.00K |
Retained Earnings | -1.56B | -1.24B | -903.35M | -646.34M | -396.12M | -211.53M | -23.00K |
Comprehensive Income | -955.00K | -9.93M | -2.57M | 268.00K | 1.15M | 306.00K | -5.00K |
Shareholders Equity | 512.23M | 665.87M | 916.41M | 1.08B | 629.02M | 703.16M | -2.00K |
Total Investments | 369.19M | 514.57M | 654.17M | 852.50M | 418.62M | 628.92M | n/a |